Moneycontrol Be a Pro
Get App
Last Updated : Oct 05, 2011 03:08 PM IST | Source: CNBC-TV18

Shasun Pharma expects 40-50% topline growth in FY12

Abhaya Kumar, managing director of Shasun Pharmaceuticals expects the company's topline to grow 40-50% in FY12. He told CNBC-TV18 in an interview that their confirmed orders for third and fourth quarter are very strong.


Abhaya Kumar, managing director of Shasun Pharmaceuticals expects the company's topline to grow 40-50% in FY12. He told CNBC-TV18 in an interview that their confirmed orders for third and fourth quarter are very strong.


The bigger concern for the company is funds availability for future projects than reducing debt on the books. However, Kumar expects to bring down debt from Rs 320 crore to Rs 220-210 crore in FY12.


Here is the edited transcript of his interview. Also watch the accompanying video.

Q: What is the quantum of debt on the company

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.

First Published on Oct 4, 2011 02:35 pm
Loading...
Follow us on
Available On